Hong Kong-listed CXO concept stocks rose in early trading, with WuXi Biologics (02269.HK) rising more than 9%, Zhaoyan Pharmaceutical (06127.HK) and WuXi AppTec (02359.HK) rising more than 4%, and Tigermed (03347.HK) rising more than 3%.

2025-03-14 09:47:02

WuXi Biologics WuXi AppTec

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Xi'an technology companies have achieved AI-customized organs and made breakthrough progress in the fields of 3D bioprinting and bionic tissue engineering
                            2025-03-19

                                    Xiaomi Group (01810.HK): Sales costs increased 35.5% from RMB 213.5 billion for the year ended December 31, 2023 to RMB 289.3 billion for the year ended December 31, 2024.
                            2025-03-18

                                    Huawei's Wang Tao: China's government and enterprise revenue growth to exceed 25% in 2024
                            2025-03-20

                                    A-share closing review: Shanghai Composite Index fluctuated slightly and fell by 0.1%, with defensive sectors such as banks, coal and electricity leading the gains
                            2025-03-19

                                    Liu Qiangdong appeared at the Hong Kong University of Science and Technology and visited several artificial intelligence projects
                            2025-03-18